Skip to main content

Table 3 The agreement between the various definitions of the MetS

From: The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012–2015

 

Revised ATP III

 

JCDCG

 

kappa

95%CI

kappa

95%CI

Men

 IDF

0.81

0.75–0.87

0.77

0.73–0.80

 Revised ATP III

  

0.86

0.85–0.88

Women

 IDF

0.89

0.86–0.92

0.58

0.56–0.60

 Revised ATP III

  

0.58

0.56–0.60

  1. MetS Metabolic syndrome, CI Confidence Interval, IDF International Diabetes Federation, Revised ATP III: the American Heart Association/National Heart, Lung, and Blood Institute updated the ATP III; JCDCG The Joint Committee for Developing Chinese Guidelines